Mylan Recalls Tranexamic Acid Injection Due to Labeling Mix-Up
Mylan Institutional LLC is recalling 1,407 cartons of Tranexamic Acid Injection due to a labeling error that may result in the wrong medication being dispensed.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The recall is classified as FDA Class I, which meets the rubric criteria for a Critical severity score due to the potential for serious adverse health consequences or death from administering the wrong medication.
Plain-English summary
Mylan Institutional LLC is recalling 1,407 cartons of Tranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vials. The recall is due to a labeling mix-up where cartons labeled as Tranexamic Acid Injection may contain vials of Amiodarone HCl Injection, USP, and cartons labeled as Amiodarone HCl Injection may contain vials of Tranexamic Acid Injection.
The affected product is distributed nationwide. The recall includes specific lot numbers 191207, 191221, 191223, and 200120, with expiration dates of 11/2021 and 12/2021. The product is manufactured by Mylan Institutional in Galway, Ireland, and manufactured for Mylan Institutional LLC in Rockford, IL.
Healthcare providers and patients should check their inventory for these specific lot numbers and expiration dates. If the product is found, it should be quarantined and not administered until further notice. This recall is classified as Class I by the FDA, indicating a reasonable probability that use of the product will cause serious adverse health consequences or death.
The recalled product
- Product
- TRANEXAMIC ACID (TRANEXAMIC ACID)
- Brand
- TRANEXAMIC ACID
- Manufacturer
- Mylan Institutional LLC
- Category
- Drug — Injection
- Affected units
- 1,407
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #: 191207
- 191221
- 191223
- Exp. 11/2021
- 200120 Exp. 12/2021
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Mylan Institutional LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · TRANEXAMIC ACID
- ModerateTranexamic Acid Tablets Recalled for Failed Manufacturing Specifications
FDA (Drugs) · 2023-06-21
- ModerateTranexamic Acid tablets recalled due to failed specification testing
FDA (Drugs) · 2023-06-21
- LowTranexamic Acid Injection Recalled for Metal Particulate Matter
FDA (Drugs) · 2022-10-12
Same manufacturer · Mylan Institutional LLC
See all →- LowThiamine HCl Injection Recall: Vials with Incorrect Lot Numbers
FDA (Drugs) · 2021-06-09
- CriticalMylan Recalls Amiodarone Hydrochloride Injection Due to Labeling Mix-Up
FDA (Drugs) · 2020-09-09
- SevereMylan Recalls Daptomycin Injection Due to Particulate Matter
FDA (Drugs) · 2020-08-12
- ModerateMylan Recalls Aloprim Injection Vials Due to Discoloration
FDA (Drugs) · 2020-05-27
- CriticalMylan Recalls Gemcitabine Injection Vials Due to Particulate Matter
FDA (Drugs) · 2015-08-26
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02